LOTTE BIOLOGICS

LOTTE BIOLOGICS stands as a premier Contract Development and Manufacturing Organization (CDMO), dedicated to enhancing global health through its comprehensive suite of services. The clinic provides end-to-end solutions that span the entire product lifecycle, from initial development to clinical and commercial production. With facilities strategically located in Syracuse, New York, and the upcoming Songdo Bio Campus in Incheon, South Korea, LOTTE BIOLOGICS boasts exceptional manufacturing capabilities—40,000 liters in Syracuse and projected 120,000 liters in Songdo—ensuring high-quality output tailored to meet the diverse needs of the biopharmaceutical industry. The clinic's robust offerings include Clinical Development Organization (CDO) services, where it assists clients with product launches, process verification, and technology transfers, as well as Contract Manufacturing Organization (CMO) services that adhere to current Good Manufacturing Practices (cGMP). Additionally, LOTTE BIOLOGICS excels in Analytical Testing Services, providing a range of quality control measures such as in-process testing and stability testing, ensuring that every product meets stringent regulatory standards. With a commitment to fostering talent and embracing diversity, LOTTE BIOLOGICS connects professionals and resources to drive innovation in healthcare, positioning itself as a pivotal player in the global landscape of biomanufacturing.